🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study was to assess whether sofosbuvir in combination with ribavirin (...
Status
Completed
Location
University of Alabama Birmingham
Start Date
2012-06
Trial ID
NCT01641640
Treatments Being Tested
The purpose of this study is to evaluate the combination of Pegylated Alfa ...
Status
Terminated
Location
Baylor College of Medicine - Methodist Hospital
Start Date
2007-05
Trial ID
NCT00522249
Treatments Being Tested
End-stage liver disease due to hepatitis C virus (HCV) is the most common i...
Status
Unknown
Location
123, Ta Pei Road, Niao Sung Hsiang
Start Date
2014-01
Trial ID
NCT02160080
Treatments Being Tested
Hepatitis C virus (HCV) infection is a leading cause of death and illness i...
Status
Completed
Location
Alabama CRS
Start Date
2012-04
Trial ID
NCT01482767
Treatments Being Tested
The purpose of this study is to evaluate if a 12-week total regimen of tela...
Status
Terminated
Location
Multiple Locations
Start Date
2011-11
Trial ID
NCT01459913
Treatments Being Tested
This is a 60-to-72 week multicenter study to evaluate Infergen and Ribaviri...
Status
Terminated
Location
Atlantic Gastroenterology Associates
Start Date
2007-02
Trial ID
NCT00456248
Treatments Being Tested
The purpose of this study is to evaluate the impact of a physician directed...
Status
Completed
Location
California Liver Institute
Start Date
2011-12
Trial ID
NCT01405027
Treatments Being Tested
This prospective, national, multicenter, non-interventional study examined ...
Status
Terminated
Location
Multiple Locations
Start Date
2014-05
Trial ID
NCT02118597
Treatments Being Tested
The purpose of this study is to determine if 48 weeks of therapy with Pegyl...
Status
Withdrawn
Location
Local Institution
Start Date
2012-03
Trial ID
NCT01447394
Treatments Being Tested
RATIONALE: PEG-interferon alfa-2b may interfere with the growth of cancer c...
Status
Terminated
Location
Robert H. Lurie Comprehensive Cancer Center at Northwestern University
Start Date
2008-09
Trial ID
NCT00724061
Treatments Being Tested